Pharmacokinetics of methylene blue dye for lymphatic mapping in breast cancer-implications for use in pregnancy.

[1]  A. Degnim,et al.  Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer. , 2008, American journal of surgery.

[2]  M. Meyers,et al.  Pregnancy‐Associated Breast Cancer Patients Can Safely Undergo Lymphatic Mapping , 2008, The breast journal.

[3]  A. Goldhirsch,et al.  Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  H. Kuerer,et al.  The Safety of Lymphatic Mapping in Pregnant Breast Cancer Patients Using Tc‐99m Sulfur Colloid , 2004, The breast journal.

[5]  O. Müller,et al.  Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria , 2004, European Journal of Clinical Pharmacology.

[6]  K. Conrad.  Mechanisms of Renal Vasodilation and Hyperfiltration During Pregnancy , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

[7]  A. Luini,et al.  Safety of sentinel node biopsy in pregnant patients with breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  R. Newcombe,et al.  Relative value of blue dye and isotope in sentinel node localization for breast cancer in a multicentre trial , 2004 .

[9]  O. Müller,et al.  Methylene blue as an antimalarial agent , 2003, Redox report : communications in free radical research.

[10]  Richard A Corley,et al.  Evaluation of Physiologically Based Models of Pregnancy and Lactation for Their Application in Children's Health Risk Assessments , 2003, Critical reviews in toxicology.

[11]  A. Stolier,et al.  A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. , 2002, American journal of surgery.

[12]  A. Derossis,et al.  A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. , 2001, Journal of the American College of Surgeons.

[13]  R. Simmons,et al.  Methylene Blue Dye as an Alternative to Isosulfan Blue Dye for Sentinel Lymph Node Localization , 2001, Annals of surgical oncology.

[14]  G. Badger,et al.  Plasma Volume Expansion in Early Pregnancy , 2001, Obstetrics and gynecology.

[15]  B. Lauterburg,et al.  Pharmacokinetics and organ distribution of intravenous and oral methylene blue , 2000, European Journal of Clinical Pharmacology.

[16]  J. Cragan.  Teratogen update: methylene blue. , 1999, Teratology.

[17]  John F. Young,et al.  Physiological "constants" for PBPK models for pregnancy. , 1997, Journal of toxicology and environmental health.

[18]  R. Porat,et al.  Methylene blue-induced phototoxicity: an unrecognized complication. , 1996, Pediatrics.

[19]  John F. Young,et al.  A physiologically based pharmacokinetic computer model for human pregnancy. , 1994, Teratology.

[20]  J. Davison,et al.  8 Volume homeostasis and osmoregulation in human pregnancy , 1989 .

[21]  McEnerney Jk,et al.  Unfavorable neonatal outcome after intraamniotic injection of methylene blue. , 1983 .

[22]  J. Crooks.  Haemolytic jaundice in a neonate after intra-amniotic injection of methylene blue , 1982 .

[23]  M. Gibaldi,et al.  Noncompartmental Analysis Based on Statistical Moment Theory , 1982 .

[24]  Robert C. Spahr,et al.  Intraamniotic Injection of Methylene Blue Leading to Methemoglobinemia in One of Twins , 1980, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[25]  I. Kirsch,et al.  Heinz body hemolytic anemia from the use of methylene blue in neonates. , 1980, The Journal of pediatrics.

[26]  J. Wagner,et al.  Pharmacokinetics of highly ionized drugs. II. Methylene blue--absorption, metabolism, and excretion in man and dog after oral administration. , 1972, Journal of pharmaceutical sciences.

[27]  J. Geiger.  METHYLENE BLUE AS ANTIDOTE FOR CYANIDE AND CARBON MONOXIDE POISONING , 1933 .

[28]  M. Brooks.  METHYLENE BLUE AS ANTIDOTE FOR CYANIDE AND CARBON MONOXIDE POISONING , 1933 .

[29]  P. Taylor,et al.  J Soc Gynecol Investig , 2005 .

[30]  T. Hurd,et al.  Breast cancer in pregnancy: a literature review. , 2003, Archives of surgery.

[31]  M. Mazumdar,et al.  Complementarity of Blue Dye and Isotope in Sentinel Node Localization for Breast Cancer: Univariate and Multivariate Analysis of 966 Procedures , 2001, Annals of Surgical Oncology.

[32]  P. Ell,et al.  Targeting disseminated melanoma with radiolabelled methylene blue , 1996 .

[33]  J. Davison,et al.  Volume homeostasis and osmoregulation in human pregnancy. , 1989, Bailliere's clinical endocrinology and metabolism.